Synapse - Chau Dang

Search Within

Chau Dang

Results (273)

Effect of unblinding on participants' perceptions of risk and confidence in a large double-blind clinical trial of chemotherapy for breast cancer

Journal Article

Partridge, A. H.; Sepucha, K.; O'Neill, A.; Miller, K. D.; Motley, C.; Swaby, R. F.; Schneider, B. P.; Dang, C. T.; Northfelt, D. W.; Sledge, G. W., Jr.
JAMA Oncology (2015)

Fulltext@MSK | Save

Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)

Meeting Abstract

Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
Cancer Research (2015)

Fulltext@MSK | Save

Continuous trastuzumab therapy in breast cancer patients with asymptomatic left ventricular dysfunction

Journal Article

Yu, A. F.; Yadav, N. U.; Eaton, A. A.; Lung, B. Y.; Thaler, H. T.; Liu, J. E.; Hudis, C. A.; Dang, C. T.; Steingart, R. M.
The Oncologist (2015)

Fulltext@MSK | Save

Cardiac safety of continuous trastuzumab therapy in breast cancer patients with asymptomatic left ventricular dysfunction

Meeting Abstract

Yu, A. F.; Yadav, N. U.; Eaton, A.; Lung, B. Y.; Thaler, H. T.; Liu, J.; Hudis, C. A.; Dang, C. T.; Steingart, R.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result

Meeting Abstract

Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Prevalence of hypomagnesemia in patients with HER2-positive breast cancer receiving pertuzumab treatment

Meeting Abstract

Proverbs-Singh, T. A.; Cadoo, K. A.; Torre, G.; Patil, S.; Gucalp, A.; Dang, C. T.; Hudis, C. A.; Glezerman, I. G.; Traina, T. A.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Characterization of dominant T-cell clones by T-cell receptor (TCR) deep sequencing as a potential predictive biomarker to neoadjuvant trastuzumab (tras) in HER2-positive (HER2+) breast cancer

Meeting Abstract

Page, D. B.; Wen, Y. H.; Brogi, E.; Yuan, J. D.; Emerson, R. O.; Patil, S.; Dang, C. T.; Norton, L.; Hudis, C. A.; Mcarthur, H. L.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Trastuzumab and pertuzumab-based versus other therapy as second-line therapy in HER2-positive metastatic breast cancer: A retrospective study from single center

Meeting Abstract

Fontes Santos De Teive Argolo, D.; Smyth, L. M.; Iyengar, N. M.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

The effect of adjuvant trastuzumab on locoregional recurrence of human epidermal growth factor receptor 2-positive breast cancer treated with mastectomy

Journal Article

Lanning, R. M.; Morrow, M.; Riaz, N.; Mcarthur, H. L.; Dang, C.; Moo, T. A.; El-Tamer, M.; Krause, K.; Siu, C.; Hsu, M.; more...
Annals of Surgical Oncology (2015)

Fulltext@MSK | Save

Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?

Journal Article

Jochelson, M. S.; Lampen Sachar, K.; Gibbons, G.; Dang, C.; Lake, D.; Morris, E. A.; Morrow, M.
Annals of Surgical Oncology (2015)

Fulltext@MSK | Save